Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Find clear guidance on which blue chip coin to start with, including risk notes and a simple starter approach for newcomers.
22,235 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Six ETFs now cover the entire grid-resilience thesis, from hardware and software to infrastructure and energy metals,...
DZ Bank moves Fortinet to Hold with a $125 price target, signaling a cautious turn in cybersecurity equities as growt...
A bold state move to end prediction markets triggers a rapid federal backlash. The ensuing lawsuit tests boundaries b...
CEOs are issuing AI token credits to teams as a new form of incentive, creating payroll-style budgets that test gover...
NVIDIA's latest financing move links chip power to optical connectivity, hinting at a broader AI infrastructure strat...
A voluntary recall of thousands of Waymo AVs grabbed headlines, but the bigger story is the decade ahead for autonomo...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
POET Technologies posted a quarterly miss as a Lumilens deal slows and litigation casts a shadow over growth prospect...
A Chinese AI lab is expanding from powering coding assistants to owning the entire toolchain. This move could reshape...
As inflation remains stubborn, a prominent podcast host argues that sitting on cash erodes real buying power. Investo...